Literature DB >> 17697161

Acute liver failure in Sweden: etiology and outcome.

G Wei1, A Bergquist, U Broomé, S Lindgren, S Wallerstedt, S Almer, P Sangfelt, A Danielsson, H Sandberg-Gertzén, L Lööf, H Prytz, E Björnsson.   

Abstract

OBJECTIVE: To determine the causes and outcome of all patients with acute liver failure (ALF) in Sweden 1994-2003 and study the diagnostic accuracy of King's College Hospital (KCH) criteria and the model for end-stage liver disease (MELD) score with transplant-free deaths as a positive outcome. RESEARCH DESIGN AND METHODS: Adult patients in Sweden with international normalized ratio (INR) of >or=1.5 due to severe liver injury with and without encephalopathy at admission between 1994-2003 were included.
RESULTS: A total of 279 patients were identified. The most common cause of ALF were acetaminophen toxicity in 42% and other drugs in 15%. In 31 cases (11%) no definite etiology could be established. The KCH criteria had a positive-predictive value (PPV) of 67%, negative-predictive value (NPV) of 84% in the acetaminophen group. Positive-predictive value and negative-predictive value of KCH criteria in the nonacetaminophen group were 54% and 63% respectively. MELD score>30 had a positive-predictive value of 21%, negative-predictive value of 94% in the acetaminophen group. The corresponding figures for the nonacetaminophen group were 64% and 76% respectively.
CONCLUSIONS: Acetaminophen toxicity was the most common cause in unselected patients with ALF in Sweden. KCH criteria had a high NPV in the acetaminophen group, and in combination with MELD score<30 predicts a good prognosis in acetaminophen patients without transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17697161     DOI: 10.1111/j.1365-2796.2007.01818.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  42 in total

1.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

Authors:  Ayako Suzuki; Raul J Andrade; Einar Bjornsson; M Isabel Lucena; William M Lee; Nancy A Yuen; Christine M Hunt; James W Freston
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 3.  Liver Failure due to Acute Viral Hepatitis (A-E).

Authors:  Paul Manka; Jens Verheyen; Guido Gerken; Ali Canbay
Journal:  Visc Med       Date:  2016-04-07

Review 4.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

5.  Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity.

Authors:  Darren G N Craig; Caroline M Bates; Janice S Davidson; Kirsty G Martin; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

6.  The Epidemiology of Acute Liver Failure.

Authors:  Nina Weiler; Andreas Schlotmann; Andreas Anton Schnitzbauer; Stefan Zeuzem; Martin-Walter Welker
Journal:  Dtsch Arztebl Int       Date:  2020-01-24       Impact factor: 5.594

7.  Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.

Authors:  K Rajender Reddy; Caitlyn Ellerbe; Michael Schilsky; R Todd Stravitz; Robert J Fontana; Valerie Durkalski; William M Lee
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

8.  Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.

Authors:  Rachel J Church; Gerd A Kullak-Ublick; Jiri Aubrecht; Herbert L Bonkovsky; Naga Chalasani; Robert J Fontana; Jens C Goepfert; Frances Hackman; Nicholas M P King; Simon Kirby; Patrick Kirby; John Marcinak; Sif Ormarsdottir; Shelli J Schomaker; Ina Schuppe-Koistinen; Francis Wolenski; Nadir Arber; Michael Merz; John-Michael Sauer; Raul J Andrade; Florian van Bömmel; Thierry Poynard; Paul B Watkins
Journal:  Hepatology       Date:  2018-06-27       Impact factor: 17.425

9.  Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity.

Authors:  Darren G N Craig; Caroline M Bates; Janice S Davidson; Kirsty G Martin; Peter C Hayes; Kenneth J Simpson
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

10.  Is nuclear factor erythroid 2-related factor 2 responsible for sex differences in susceptibility to acetaminophen-induced hepatotoxicity in mice?

Authors:  Philip R Rohrer; Swetha Rudraiah; Michael J Goedken; José E Manautou
Journal:  Drug Metab Dispos       Date:  2014-08-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.